Journal Guide

Translating molecular bioscience and experimental research into medical insights, Clinical Science offers comprehensive studies using a multi-disciplinary approach including models of human disease and clinical perspectives to advance human health.

Its international Editorial Board is charged with selecting peer-reviewed original papers of the highest scientific merit covering the broad spectrum of biomedical specialities including, although not exclusively:

Cardiovascular system
Cerebrovascular system
Gastrointestinal tract and liver
Genomic medicine
Infection and immunity
Inflammation
Oncology
Metabolism
Endocrinology and nutrition
Nephrology
Circulation
Respiratory system
Vascular biology
Molecular pathology

Clinical Skin Cancer publishes original articles describing various aspects of clinical and translational research of skin malignancies and is devoted to articles on detection, diagnosis, prevention, and treatment of skin malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Our mission is to be the premier source of clinically relevant information through promoting excellence in clinical research and facilitating the timely translation of that science to health care and clinical practice. Key objectives to achieve these goals include the nurturing and development of future generations of clinical scientists, and the dissemination of new knowledge related to skin malignancies.

Founded in 1973, the Clinical Social Work Journal publishes leading, peer-reviewed original articles relevant to contemporary clinical practice with individuals, couples, families, and groups. It also presents innovations in theoretical, practice, evidence-based clinical research, and interdisciplinary approaches. The Clinical Social Work Journal is devoted to the advancement of clinical knowledge and insight of practitioners, educators, researchers, and policymakers

Clinical Therapeutics is dedicated to the dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches to an international audience of scientists and clinicians working in a variety of research, academic, and clinical practice settings. Providing such information is especially important in this era of harmonization and globalization of drug development. Clinical Therapeutics strives to achieve its mission by providing peer-reviewed, rapid publication of recent developments in drug therapies, as well as in-depth review articles on specific agents, treatment strategies, and disease states. Most articles are available online within 20 business days after acceptance. Articles appearing in Clinical Therapeutics are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolerability in all phases of development; new routes of administration and new formulations; pharmacokinetic, bioavailability, bioequivalence and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.

Clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology and the European Association of Poisons Centres and Clinical Toxicologists and, as such, is the leading international journal in the specialty.

Clinical Transplantation is primarily designed as a channel of communication for all those involved in the care of people who require or have had organ or tissue transplants, including: kidney, intestine, liver, pancreas, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored. Interest is focused not only on the complete spectrum of present transplant operations, but also those that are experimental or may become possible in future.

Clinical Trials: Journal of the Society for Clinical Trials is an international peer reviewed scholarly journal whose primary aim is the dissemination and development of knowledge about the design, conduct, analysis, synthesis, history, ethics, regulation and clinical or policy impact of all types of clinical trials and related medical research methodologies.

Clinical and Applied Thrombosis/Hemostasis is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders. Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal are of appeal to any person interested in clinical and applied thrombohemorrhagic disorders.

Clinical and Experimental Dermatology (CED) is a unique provider of relevant and accessible material of educational value to practising clinicians and dermatological researchers. In supporting the continuing professional development (CPD) of dermatology specialists, the journal aims to advance understanding, management and treatment of skin disease and improve patient outcomes. In addition to a dedicated CPD section, CED publishes review articles, original papers, concise reports and items of correspondence. CED is an official organ of the British Association of Dermatologists but attracts contributions from all countries in which sound clinical practice is conducted, and its circulation is equally international. Journal content and further information - including author guidelines and submission details - can be found online at www.clinexpdermatol.org. The 2010 impact factor is 1.267. Have you seen the CPD section? Every issue of Clinical and Experimental Dermatology includes multiple CPD articles with the following features:

Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions. Features special issues covering proceedings of symposia on hypertension research! Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including antihypertensive agents circulatory control drug development and application etiology mechanisms of action neurogenic mechanisms pathophysiology pharmacological and nonpharmacological treatment and much more! Interdisciplinary in scope, the journal reaches specialists in biochemistry cardiology endocrinology family practice medicine geriatrics gynecology/obstetrics immunology internal medicine nephrology neurology pathology pediatrics pharmacology physiology toxicology.

Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields: clinical chemistry, hematology, immunology, oncology and virology. The major criteria for publication will be clarity, experimental soundness and advances in knowledge. Papers containing new clinical or experimental data, or which are likely to contribute to changes in clinical practice or in thinking about a disease will be given priority due to their immediate importance.The following types of articles will be considered for publication: invited or unsolicited Reviews and Editorials; Original papers; Short communications; Letters to the Editor. Submission of case reports, clinical trials and epidemiological studies is not encouraged. The Editor-in-Chief will under certain circumstances consider for publication monothematic issues and supplements devoted to congress proceedings.

Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of fundamental advances in basic and applied metastasis research.The coverage encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It includes such areas as molecular biology, pharmacology, tumour biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the journal's core subject of metastasis formation, prevention and treatment.Clinical & Experimental Metastasis is the official journal of the Metastasis Research Society.

Clinical and Experimental Nephrology is a peer-reviewed bimonthly journal, officially published by the Japanese Society of Nephrology (JSN) to create an international forum for the discussion of research and issues relating to the study of nephrology. The term 'nephrology' in the title was created and brought into use with the establishment of JSN (Japanese Journal of Nephrology, Vol. 2, No.1, 1960). The journal publishes articles on all aspects of nephrology, including basic, experimental, and clinical research, providing a means of sharing research findings and ideas for the members of JSN, and for all researchers who wish to contribute to a better understanding of advances in nephrology. Uniquely, the journal introduces to an international readership original reports from Japan and also the clinical standards discussed and agreed by JSN.